| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5896843 | Cytokine | 2016 | 7 Pages | 
Abstract
												IL-16 was a more effective clinical parameter than MMP-3, C-reactive protein, or erythrocyte sedimentation rate in both MTX-naive and MTX-IR RA patients. IL-16 might be a useful biomarker for evaluating clinical response in RA patients.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Endocrinology
												
											Authors
												Atsuko Murota, Katsuya Suzuki, Yoshiaki Kassai, Takahiro Miyazaki, Rimpei Morita, Yasushi Kondo, Masaru Takeshita, Yasuo Niki, Akihiko Yoshimura, Tsutomu Takeuchi, 
											